Benefit of percutaneous coronary intervention in early latecomers with acute ST-segment elevation myocardial infarction

Doo Sun Sim, Myung Ho Jeong, Youngkeun Ahn, Young Jo Kim, Shung Chull Chae, Taek Jong Hong, In Whan Seong, Jei Keon Chae, Chong Jin Kim, Myeong Chan Cho, Seung-Woon Rha, Jang Ho Bae, Ki Bae Seung, Seung Jung Park

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The clinical benefit of percutaneous coronary intervention (PCI) is controversial in stable early latecomers with ST-segment elevation myocardial infarction (STEMI). We evaluated the efficacy of PCI in 2,344 stable patients with STEMI presenting 12 to 72 hours after symptom onset. Patients who had impaired hemodynamics or who had undergone fibrinolysis or immediate or urgent PCI were excluded. The patients were divided into the PCI group (n = 1,889) and medical treatment group (n = 455). The 12-month clinical outcome was compared between the 2 groups. After adjustment using propensity score stratification, the PCI group had lower mortality (3.1% vs 10.1%; hazard ratio 0.31; 95% confidence interval 0.20 to 0.47; p <0.001) and a lower incidence of composite death/myocardial infarction (3.8% vs 11.2%; hazard ratio 0.36; 95% confidence interval 0.25 to 0.53; p <0.001) at 12 months. The benefit of PCI was consistent across all subgroups, including patients presenting without chest pain. In conclusion, in stable patients with STEMI presenting 12 to 72 hours after symptom onset, PCI was associated with significant improvement in the 12-month clinical outcome.

Original languageEnglish
Pages (from-to)1275-1281
Number of pages7
JournalAmerican Journal of Cardiology
Volume110
Issue number9
DOIs
Publication statusPublished - 2012 Oct 1

Fingerprint

Percutaneous Coronary Intervention
Myocardial Infarction
Confidence Intervals
Propensity Score
Fibrinolysis
ST Elevation Myocardial Infarction
Chest Pain
Hemodynamics
Mortality
Incidence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Benefit of percutaneous coronary intervention in early latecomers with acute ST-segment elevation myocardial infarction. / Sim, Doo Sun; Jeong, Myung Ho; Ahn, Youngkeun; Kim, Young Jo; Chae, Shung Chull; Hong, Taek Jong; Seong, In Whan; Chae, Jei Keon; Kim, Chong Jin; Cho, Myeong Chan; Rha, Seung-Woon; Bae, Jang Ho; Seung, Ki Bae; Park, Seung Jung.

In: American Journal of Cardiology, Vol. 110, No. 9, 01.10.2012, p. 1275-1281.

Research output: Contribution to journalArticle

Sim, DS, Jeong, MH, Ahn, Y, Kim, YJ, Chae, SC, Hong, TJ, Seong, IW, Chae, JK, Kim, CJ, Cho, MC, Rha, S-W, Bae, JH, Seung, KB & Park, SJ 2012, 'Benefit of percutaneous coronary intervention in early latecomers with acute ST-segment elevation myocardial infarction', American Journal of Cardiology, vol. 110, no. 9, pp. 1275-1281. https://doi.org/10.1016/j.amjcard.2012.06.028
Sim, Doo Sun ; Jeong, Myung Ho ; Ahn, Youngkeun ; Kim, Young Jo ; Chae, Shung Chull ; Hong, Taek Jong ; Seong, In Whan ; Chae, Jei Keon ; Kim, Chong Jin ; Cho, Myeong Chan ; Rha, Seung-Woon ; Bae, Jang Ho ; Seung, Ki Bae ; Park, Seung Jung. / Benefit of percutaneous coronary intervention in early latecomers with acute ST-segment elevation myocardial infarction. In: American Journal of Cardiology. 2012 ; Vol. 110, No. 9. pp. 1275-1281.
@article{99827b32e7d04109b5f6ab6993278aba,
title = "Benefit of percutaneous coronary intervention in early latecomers with acute ST-segment elevation myocardial infarction",
abstract = "The clinical benefit of percutaneous coronary intervention (PCI) is controversial in stable early latecomers with ST-segment elevation myocardial infarction (STEMI). We evaluated the efficacy of PCI in 2,344 stable patients with STEMI presenting 12 to 72 hours after symptom onset. Patients who had impaired hemodynamics or who had undergone fibrinolysis or immediate or urgent PCI were excluded. The patients were divided into the PCI group (n = 1,889) and medical treatment group (n = 455). The 12-month clinical outcome was compared between the 2 groups. After adjustment using propensity score stratification, the PCI group had lower mortality (3.1{\%} vs 10.1{\%}; hazard ratio 0.31; 95{\%} confidence interval 0.20 to 0.47; p <0.001) and a lower incidence of composite death/myocardial infarction (3.8{\%} vs 11.2{\%}; hazard ratio 0.36; 95{\%} confidence interval 0.25 to 0.53; p <0.001) at 12 months. The benefit of PCI was consistent across all subgroups, including patients presenting without chest pain. In conclusion, in stable patients with STEMI presenting 12 to 72 hours after symptom onset, PCI was associated with significant improvement in the 12-month clinical outcome.",
author = "Sim, {Doo Sun} and Jeong, {Myung Ho} and Youngkeun Ahn and Kim, {Young Jo} and Chae, {Shung Chull} and Hong, {Taek Jong} and Seong, {In Whan} and Chae, {Jei Keon} and Kim, {Chong Jin} and Cho, {Myeong Chan} and Seung-Woon Rha and Bae, {Jang Ho} and Seung, {Ki Bae} and Park, {Seung Jung}",
year = "2012",
month = "10",
day = "1",
doi = "10.1016/j.amjcard.2012.06.028",
language = "English",
volume = "110",
pages = "1275--1281",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Benefit of percutaneous coronary intervention in early latecomers with acute ST-segment elevation myocardial infarction

AU - Sim, Doo Sun

AU - Jeong, Myung Ho

AU - Ahn, Youngkeun

AU - Kim, Young Jo

AU - Chae, Shung Chull

AU - Hong, Taek Jong

AU - Seong, In Whan

AU - Chae, Jei Keon

AU - Kim, Chong Jin

AU - Cho, Myeong Chan

AU - Rha, Seung-Woon

AU - Bae, Jang Ho

AU - Seung, Ki Bae

AU - Park, Seung Jung

PY - 2012/10/1

Y1 - 2012/10/1

N2 - The clinical benefit of percutaneous coronary intervention (PCI) is controversial in stable early latecomers with ST-segment elevation myocardial infarction (STEMI). We evaluated the efficacy of PCI in 2,344 stable patients with STEMI presenting 12 to 72 hours after symptom onset. Patients who had impaired hemodynamics or who had undergone fibrinolysis or immediate or urgent PCI were excluded. The patients were divided into the PCI group (n = 1,889) and medical treatment group (n = 455). The 12-month clinical outcome was compared between the 2 groups. After adjustment using propensity score stratification, the PCI group had lower mortality (3.1% vs 10.1%; hazard ratio 0.31; 95% confidence interval 0.20 to 0.47; p <0.001) and a lower incidence of composite death/myocardial infarction (3.8% vs 11.2%; hazard ratio 0.36; 95% confidence interval 0.25 to 0.53; p <0.001) at 12 months. The benefit of PCI was consistent across all subgroups, including patients presenting without chest pain. In conclusion, in stable patients with STEMI presenting 12 to 72 hours after symptom onset, PCI was associated with significant improvement in the 12-month clinical outcome.

AB - The clinical benefit of percutaneous coronary intervention (PCI) is controversial in stable early latecomers with ST-segment elevation myocardial infarction (STEMI). We evaluated the efficacy of PCI in 2,344 stable patients with STEMI presenting 12 to 72 hours after symptom onset. Patients who had impaired hemodynamics or who had undergone fibrinolysis or immediate or urgent PCI were excluded. The patients were divided into the PCI group (n = 1,889) and medical treatment group (n = 455). The 12-month clinical outcome was compared between the 2 groups. After adjustment using propensity score stratification, the PCI group had lower mortality (3.1% vs 10.1%; hazard ratio 0.31; 95% confidence interval 0.20 to 0.47; p <0.001) and a lower incidence of composite death/myocardial infarction (3.8% vs 11.2%; hazard ratio 0.36; 95% confidence interval 0.25 to 0.53; p <0.001) at 12 months. The benefit of PCI was consistent across all subgroups, including patients presenting without chest pain. In conclusion, in stable patients with STEMI presenting 12 to 72 hours after symptom onset, PCI was associated with significant improvement in the 12-month clinical outcome.

UR - http://www.scopus.com/inward/record.url?scp=84867401103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867401103&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2012.06.028

DO - 10.1016/j.amjcard.2012.06.028

M3 - Article

VL - 110

SP - 1275

EP - 1281

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 9

ER -